In this episode, we are joined by Col. Philip Blair MD. Col. Philip Blair, MD, is a board-certified Family Physician licensed in Washington State. After retiring from the Army in 1996 he managed workers injuries and provided primary care above the Arctic Circle in Alaska. In 2000 he became Vice President for Disease Management at AWAC, Inc., an medical management company, where he co-developed a highly successful interventional approach to chronic kidney disease. In 2011 he formed his own company consulting for employer-based health insurers and providing a revolutionary style of chronic disease management achieving success in over 75% of patients with diabetes, kidney disease, heart disease, and metabolic syndrome.
Topics:
1. Endocannabinoid Receptors
2. Systematic Inflammation
3. Receptor Targeting Formulations
* Twitter - @TheCannabisRev2
* LinkedIn - @thecannabisreview
* Episode Library - https://www.thecannabisreview.ie
+ https://drcanna.com/ for UK & Ireland
+ https://www.blairmedicalgroup.eu
